AI Reshapes Drug Development Workflows, But Breakthrough Molecules Still Elusive sheeba farhat27 Jan 2026 2:05 PM ISTDrug companies have announced a slew of deals for tools to unleash the promise of AI, seen as the biggest technological upheaval since the internet,...
GSK to Acquire RAPT Therapeutics for USD 2.2 Billion, Bolsters Food Allergy Drug Pipeline sheeba farhat26 Jan 2026 1:13 PM ISTLondon: Britain's GSK has agreed to buy RAPT Therapeutics for USD 2.2 billion, accessing the U.S. biotech's experimental drug to treat food allergies...
Malaria Vaccine Significantly Reduces Malaria Incidence in Children in real-world study Dr. Shravani Dali22 Jan 2026 9:00 PM ISTAn interim phase 4 analysis published in The Lancet Global Health reported that children who received the RTS,S/AS01E malaria vaccine experienced...
Pfizer Sells ViiV Stake for USD 1.9 Billion, Shionogi Emerges Bigger Partner sheeba farhat21 Jan 2026 5:47 PM ISTPfizer in December had warned that the next few years would be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and treatment,...
FDA Approves Depemokimab-ulaa as First Twice-Yearly Biologic for Severe Eosinophilic Asthma Dr. Kamal Kant Kohli21 Dec 2025 8:45 PM ISTDepemokimab-ulaa (Exdensur) has been approved by the US FDA as add-on maintenance therapy for severe asthma with an eosinophilic phenotype in patients...
GSK twice yearly Exdensur secures USFDA approval for severe asthma Ruchika Sharma17 Dec 2025 12:30 PM ISTLondon: GSK has received approval from the US Food and Drug Administration (FDA) for Exdensur (depemokimab-ulaa) as an add-on maintenance...
GSK Nucala receives positive EMA Committee opinion for COPD Ruchika Sharma13 Dec 2025 3:32 PM ISTLondon: GSK has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the...
GSK Blujepa gets USFDA approval as oral option for uncomplicated urogenital gonorrhoea Ruchika Sharma13 Dec 2025 11:30 AM ISTLondon: GSK has announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application for gepotidacin as an...
FDA Approves First New Oral Antibiotic Class for Gonorrhea in 30+ Years Dr. Kamal Kant Kohli12 Dec 2025 10:30 AM ISTThe FDA has approved GSK's gepotidacin (Blujepa), the first new antibiotic class for gonorrhea in over three decades, offering a crucial option amid...
GSK risvutatug rezetecan gets USFDA Orphan Drug Designation for lung cancer Ruchika Sharma11 Dec 2025 10:30 AM ISTLondon: GSK plc has announced that its B7-H3-targeted antibody-drug conjugate GSK'227, now referred to by its International Nonproprietary Name,...
Novartis names Sreeman Balineni as new Executive Director Ruchika Sharma30 Nov 2025 4:00 PM ISTNovartis has appointed Sreeman Balineni as its new Executive Director.Before joining Novartis, he served as Senior Director, GCC India Head-...
GSK, LTZ collaborate to advance novel myeloid cell engagers in oncology Ruchika Sharma23 Nov 2025 2:30 PM ISTLondon: GSK plc and LTZ Therapeutics, an immunotherapy-focused biotechnology company based in Redwood City, California, have announced a...
